Publications


A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis.
Cancer Cell 2017 Jun;31(6):804-819.e7
Department of Pathology, New York University School of Medicine, New York, NY 10016, USA; Interdisciplinary Melanoma Cooperative Group, Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016, USA. Electronic address:

MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway.
Pigment Cell Melanoma Res 2017 May 19;30(3):328-338. Epub 2017 Apr 19.
Department of Pathology, NYU School of Medicine, NYU Langone Medical Center, New York, NY, USA.

A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Clin Cancer Res 2015 Nov 18;21(21):4903-12. Epub 2015 Jun 18.
Department of Pathology, NYU School of Medicine, New York, NYU School of Medicine. Interdisciplinary Melanoma Cooperative Group, NYU Perlmutter Cancer Institute, NYU School of Medicine, New York, New York.

Histone Variant H2A.Z.2 Mediates Proliferation and Drug Sensitivity of Malignant Melanoma.
Mol Cell 2015 Jul 4;59(1):75-88. Epub 2015 Jun 4.
Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address:

Identification of metastasis-suppressive microRNAs in primary melanoma.
J Natl Cancer Inst 2015 Mar 12;107(3). Epub 2015 Feb 12.
Department of Pathology (DH, MFS, EP, XJS, FD, EH), Interdisciplinary Melanoma Cooperative Group (DH, MFS, JZ, XJS, FD, RSB, RLS, AP, IO, EH), Department of Environmental Medicine (JZ), Department of Dermatology (AP, IO), Department of Medicine (AP, IO), Department of Urology (IO); Department of Surgery (RSB, RLS), NYU Langone Medical Center, New York, NY; Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY (BB).


Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients.
Cancer 2015 Jan 25;121(1):51-9. Epub 2014 Aug 25.
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York; Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, New York.

Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genes.
Cell Rep 2014 Oct 26;9(1):234-47. Epub 2014 Sep 26.
Department of Pathology, New York University School of Medicine, and Perlmutter Cancer Center, New York, NY 10016, USA; Helen L. and Martin S. Kimmel Center for Stem Cell Biology, NYU Langone Medical Center, New York, NY 10016, USA. Electronic address:

Anti-miR182 reduces ovarian cancer burden, invasion, and metastasis: an in vivo study in orthotopic xenografts of nude mice.
Mol Cancer Ther 2014 Jul 13;13(7):1729-39. Epub 2014 May 13.
Pathology and Obstetrics and Gynecology; Robert H. Lurie Comprehensive Cancer Center, Northwestern University School of Medicine, Chicago, Illinois;

Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis.
Melanoma Res 2013 Dec;23(6):461-7
aDepartments of Population Health and Environmental Medicine bRonald O. Perelman Department of Dermatology cInterdisciplinary Melanoma Cooperative Group dDepartment of Pathology, New York University School of Medicine eNew York University Cancer Institute, New York, New York, USA.

BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy.
Cancer Res 2013 Oct 15;73(20):6264-76. Epub 2013 Aug 15.
Authors' Affiliations: Departments of Pathology and Dermatology, New York University School of Medicine; Interdisciplinary Melanoma Cooperative Group, New York University Cancer Institute, New York University Langone Medical Center; Departments of Structural and Chemical Biology and Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Instituto de Salud Carlos III, Majadahonda, Madrid; and Laboratory of Translational Research in Childhood Cancer, Vall d'Hebrón Institut de Recerca (VHIR), Barcelona, Spain.


MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells.
Hum Mol Genet 2012 May 10;21(10):2157-65. Epub 2012 Feb 10.
Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), E-28029 Madrid, Spain.



Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival.
Cancer 2011 Apr 8;117(8):1711-20. Epub 2010 Nov 8.
The New York University Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine and New York University Cancer Institute, New York, New York, USA.

HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes.
Cancer Res 2011 Jan 11;71(2):349-59. Epub 2011 Jan 11.
Key Laboratory for Experimental Teratology of the Ministry of Education, Institute of Molecular Medicine and Genetics, Shandong University School of Medicine, PR China.


Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.
Proc Natl Acad Sci U S A 2009 Feb 2;106(6):1814-9. Epub 2009 Feb 2.
Department of Pathology, Interdisciplinary Melanoma Cooperative Group, New York University Medical Center. New York, NY 10016, USA.


Chemokine signaling via the CXCR2 receptor reinforces senescence.
Cell 2008 Jun;133(6):1006-18
Cell Proliferation Group, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Campus, W12 0NN London, UK.


OF